Status Complete
Estimated value without VAT 45 000 MDL
  • Winner: IM"Becor"SRL
  • Cost: 33 471 MDL
  • Saved: 25.62 %
  • Of participants: 2
Period of clarifications: 20.04.18 16:21 - 23.04.18 11:00
Submission of proposals: 23.04.18 16:00 - 26.04.18 11:00
Auction start date: 27 Apr 2018 14:08

Supplier technical support:

(+373) 79999801

1
Information about customer
Fiscal code/IDNO
Address
4571, Moldova, Dubasari, Cocieri, Tarmului 1B
Web site
---
The contact person
Full name
Angela Netid
Contact phone
---
Purchase data
Type of procedure
Low value procedure
Estimated value (without VAT)
45 000 MDL
The minimum downward of the price
180 MDL
Date of last modifications
4 May 2018 15:27
ID
688a577ce95a4134af640f13487c63e0
List of positions
1)
Title
produse farmaceutice CPV: 33000000-0 - Medical equipments, pharmaceuticals and personal care products
Delivery address: 4571, MD, Dubasari, Cocieri, Tarmului 1B
Delivery period: 30 Apr 2018 16:13 - 30 May 2018 16:14
Quantity: 1
Unit of measurement: lot [unit of procurement]
Documents of the procurement procedure
Document's name
MSIGN
inv med.pdf inv med.pdf
Bidding Documents
20.04.18 16:21
Participants list
Qualification
1
Participant(s) name(s):

Farmacia Cojusna

Normalized price: 12 973,24 MDL
Status: Disqualified
descalificarea lotului
din motiv că majoritatea denumiri nus din invitatia propusa
Qualification documents
Documents folder missing
Documents provided with the proposal
2
Participant(s) name(s):

IM"Becor"SRL

Tender completed
Normalized price: 33 471 MDL
Status: Winner
cistigatorul
ati stat cistigator pe loturi
Qualification documents
Documents folder missing
Documents provided with the proposal
Auction
1
Participant(s) name(s): Farmacia Cojusna
Normalized price: 12 973,24 MDL
Documents provided with the proposal
2
Participant(s) name(s): IM"Becor"SRL
Normalized price: 33 471 MDL
Documents provided with the proposal
Contract
View contract
The history of the auction
View auction
Litigation
File an appeal
Unfortunately, questions can be asked only during the "Enquiry period" period.
Clarifications